missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human LRRC26 (aa 44-85) Control Fragment Recombinant Protein
Click to view available options
Quantity:
100 μL
Unit Size:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (67%), Rat (67%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-63285 (PA5-63285. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
The LRRC26 protein was initially identified as a cytokeratin-associated protein whose expression was elevated in multiple cancer cell lines and cancer specimens as well in normal prostate and salivary gland tissues. LRRC26 was later found to negatively regulate the NF-kappaB activation and suppresses tumor growth and metastasis. LRRC26 can also act to selectively alter the efficacy of large conductance calcium-activated K (BK) channels.
Specifications
Specifications
| Accession Number | Q2I0M4 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 389816 |
| Name | Human LRRC26 (aa 44-85) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | bA350O14.10; BK channel auxiliary gamma subunit LRRC26; BK channel auxilliary gamma subunit LRRC26; CAPC; cytokeratin associated protein; cytokeratin-associated protein in cancer; leucine rich repeat containing 26; leucine-rich repeat-containing protein 26; Lrrc26; RGD1308398 |
| Common Name | LRRC26 |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction